Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

BACKGROUND: Symptomatic patients with chronic obstructive pulmonary disease (COPD) and low exacerbation risk still have disease instability, which can be improved with better bronchodilation. We evaluated two long-acting bronchodilators individually and in combination on reducing exacerbation risk a...

Descripción completa

Detalles Bibliográficos
Autores principales: Naya, Ian, Tombs, Lee, Lipson, David A., Boucot, Isabelle, Compton, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434823/
https://www.ncbi.nlm.nih.gov/pubmed/30914064
http://dx.doi.org/10.1186/s12931-019-1027-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434823/
https://www.ncbi.nlm.nih.gov/pubmed/30914064
http://dx.doi.org/10.1186/s12931-019-1027-9

Ejemplares similares